Wilson Compton

Dr. Wilson Compton

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2016 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
WCWilson Compton
Wilson Compton
CJChristopher M Jones
Christopher M Jones
GBGrant T Baldwin
Grant T Baldwin
The nonmedical use of prescription opioids is a major public health issue in the United States, both because of the overall high prevalence and because of marked increases in associated morbidity and mortality.1 In 2014, a total of 10.3 million persons reported using prescription opioids nonmedically (i.e., using medications that were not prescribed for them or were taken only for the experience or feeling that they caused).2 Emergency department visits involving misuse or abuse of prescription opioids increased 153% between 2004 and 2011, and admissions to substance-abuse treatment programs linked to prescription opioids more than quadrupled between 2002 and 2012.3,4 Most troubling, between 2000 and 2014 the rates of death from prescription-opioid overdose nearly quadrupled (from 1.5 to 5.9 deaths per 100,000 persons) ( Figure 1 ).

5 September 2017 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
BHBeth HAN
Beth HAN
WCWilson Compton
Wilson Compton
CBCarlos Blanco
Carlos Blanco
ECElizabeth Crane
Elizabeth Crane
JLJinhee Lee
Jinhee Lee
CJChristopher M. Jones
Christopher M. Jones
Despite the continuing epidemic of opioid misuse, data on the prevalence of prescription opioid use, misuse, and use disorders are limited. To estimate the prevalence of prescription opioid use, misuse, and use disorders and motivations for misuse among U.S. adults. Survey. The 2015 National Survey on Drug Use and Health (NSDUH). 72 600 eligible civilian, noninstitutionalized adults were selected for NSDUH, and 51 200 completed the survey interview. Prescription opioid use, misuse, and use disorders. Weighted NSDUH estimates suggested that, in 2015, 91.8 million (37.8%) U.S. civilian, noninstitutionalized adults used prescription opioids; 11.5 million (4.7%) misused them; and 1.9 million (0.8%) had a use disorder. Among adults with prescription opioid use, 12.5% reported misuse; of these, 16.7% reported a prescription opioid use disorder. The most commonly reported motivation for misuse was to relieve physical pain (63.4%). Misuse and use disorders were most commonly reported in adults who were uninsured, were unemployed, had low income, or had behavioral health problems. Among adults with misuse, 59.9% reported using opioids without a prescription, and 40.8% obtained prescription opioids for free from friends or relatives for their most recent episode of misuse. Cross-sectional, self-reported data. More than one third of U.S. civilian, noninstitutionalized adults reported prescription opioid use in 2015, with substantial numbers reporting misuse and use disorders. Relief from physical pain was the most commonly reported motivation for misuse. Economic disadvantage and behavioral health problems may be associated with prescription opioid misuse. The results suggest a need to improve access to evidence-based pain management and to decrease excessive prescribing that may leave unused opioids available for potential misuse. U.S. Department of Health and Human Services.

5 May 2004 in JAMA
Verified
Journal Article
Open access
PDF file
WCWilson Compton
Wilson Compton
BGBridget F. Grant
Bridget F. Grant
JCJames D. Colliver
James D. Colliver
MGMeyer D. Glantz
Meyer D. Glantz
FSFrederick S. Stinson
Frederick S. Stinson
Marijuana has been the most common illicit substance used in the United States for several decades.1,2 Understanding changes in the use of marijuana over time is important for a number of reasons. Marijuana use is associated with impaired educational attainment,3 reduced workplace productivity,4 and increased risk of use of other substances.5 Marijuana use plays a major role in motor vehicle crashes6 and has adverse effects on the respiratory and cardiovascular systems.7-10

1 October 2016 in The Lancet Psychiatry
Verified
Journal Article
Closed access
WCWilson Compton
Wilson Compton
BHBeth Han
Beth Han
CJChristopher M Jones
Christopher M Jones
CBCarlos Blanco
Carlos Blanco
AHArthur Hughes
Arthur Hughes

13 November 2020 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
WCWilson Compton
Wilson Compton
RVRita J. Valentino
Rita J. Valentino
RDRobert L. DuPont
Robert L. DuPont
Interventions to address the U.S. opioid crisis primarily target opioid use, misuse, and addiction, but because the opioid crisis includes multiple substances, the opioid specificity of interventions may limit their ability to address the broader problem of polysubstance use. Overlap of opioids with other substances ranges from shifts among the substances used across the lifespan to simultaneous co-use of substances that span similar and disparate pharmacological categories. Evidence suggests that nonmedical opioid users quite commonly use other drugs, and this polysubstance use contributes to increasing morbidity and mortality. Reasons for adding other substances to opioids include enhancement of the high (additive or synergistic reward), compensation for undesired effects of one drug by taking another, compensation for negative internal states, or a common predisposition that is related to all substance consumption. But consumption of multiple substances may itself have unique effects. To achieve the maximum benefit, addressing the overlap of opioids with multiple other substances is needed across the spectrum of prevention and treatment interventions, overdose reversal, public health surveillance, and research. By addressing the multiple patterns of consumption and the reasons that people mix opioids with other substances, interventions and research may be enhanced.

1 May 2003 in American Journal of Psychiatry
Verified
Journal Article
Closed access
WCWilson Compton
Wilson Compton
LCLinda B. Cottler
Linda B. Cottler
JJJacqueline L. Jacobs
Jacqueline L. Jacobs
ABArbi Ben-Abdallah
Arbi Ben-Abdallah
ESEdward L. Spitznagel
Edward L. Spitznagel